Loading…
Psychedelic Science 2023
Attending this event?

Log in to bookmark your favorites and sync them to your phone or calendar.

Monday, June 19
 

9:00am MDT

Ecopsychedelic Practices for Addressing Eco/Social Crises
Additional registration fee applies.

In the face of our ecological (global climate chaos, sixth mass extinction, etc.) and social crises (global resurgence of fascism, increasing military tensions and new wars, etc.), finding ways to connect with nature, address issues of environmental justice and ecoanxiety/trauma, and foster novel solutions to our problems is more important than ever. Ecopsychedelics offer a unique opportunity to do all three. This workshop will explore the intersection of ecopsychology and psychedelics through theory as well as practices that are designed to overcome the disconnections between an individual and their true self, other humans, the more-than-human world, and the ground of Being. By exploring the intersection between ecology, justice, psychology, and psychedelics, humanity may find new ways to tackle some of the most pressing challenges facing our planet today. With the psychedelic resurgence underway, the possibility of using these medicines in both clinical and environmental contexts with the intention of deepening individual connection to the planet, and our collective liberation, can help people develop a fuller understanding of the importance of working together to preserve and honor our planet by building just and sustainable societies.

Format: The session will include the following elements:

  • Practice: Participants will be guided through a number of exercises designed to help them connect with nature and foster empathy for the natural world. They will also have the opportunity to share their experiences and learn from others in the group. 
  • Lecture: We will discuss the latest research and theories on nature and psychedelic use and their potential to help us heal our relationship with nature and transform unjust and unsustainable systems. A panel of practitioners will also be on hand to share their insights and answer questions. 
  • Small Group Discussion: In one break out session, attendees will share their thoughts and experiences about how psychedelics can help us connect with nature on a deeper level. Another session will discuss how ecopsychedelics can be used to help address the global climate crisis, injustices, as well as other pressing environmental and social challenges.


Instructors include:

  • Azul DelGrasso, Ph.Dc.
  • Michal (Miki) Fire, Psy.D.
  • Travis Cox, Ph.D.
Monday June 19, 2023 9:00am - 1:00pm MDT
TBA
  Workshops, Morning

9:00am MDT

Guiding Psilocybin Therapy Sessions
Additional registration fee applies.

In this workshop, Mary will present on compassion, connection, authenticity, play, and therapeutic competencies. She will cover the primary therapeutic competencies necessary for guiding psychedelic-assisted psychotherapy and their importance for guiding psychedelic sessions with emphasis on presence, care, connection and non-directive support. Also covered will be the importance of establishing a safe set and setting in sessions with focus on safety issues, intentions and comfort.
There will be discussion on the use of guided imagery in psychedelic-assisted therapy specifying when to use, how to use it and references to different types of guided imagery as well as a discussion on integration. Experiential learning and practice via guided imageries and break out groups will to be used to incorporate the information and techniques discussed. Question and answer periods will follow each segment.

Instructor:

  • Mary Cosimano, LMSW
Monday June 19, 2023 9:00am - 5:00pm MDT
TBA
  Workshops, Full Day

9:00am MDT

Introduction to Psilocybin as a Tool in Personal and Spiritual Development
Psilocybin, the use of which echoes back at least to 500 BC, is now re-emerging in Western culture with promise in arenas of medicine, education and religion. In the hope that we have sufficiently evolved to constructively integrate this powerful sacramental substance into society in wise, safe and responsible ways, this workshop focuses on the fundamental knowledge required.  Among other topics, it will consider prerequisites for safe use, the potent variables of mental set and physical setting, the vast varieties of inner worlds awaiting exploration and the challenges of integrating new insights and perspectives into everyday living.

Instructors include:

  • Brian D. Richards, Psy.D.
  • William A. Richards, Ph.D.
Monday June 19, 2023 9:00am - 5:00pm MDT
TBA
  Workshops, Full Day

9:00am MDT

Introduction to Psychedelic Therapy for Addiction
Additional registration fee applies.

This course will focus on the treatment of addictions with psychedelics. We will cover historical and modern research suggesting anti-addiction treatment efficacy for psychedelic compounds. We will review psychotherapeutic modalities used to facilitate psychedelic treatment of addiction (e.g., cognitive behavioral therapy). Methods for ensuring safety and maximizing efficacy will be explored. We will also explore future directions for the future of psychedelic compounds in the treatment of addictions.

Instructor:

  • Matthew W. Johnson, Ph.D.
Monday June 19, 2023 9:00am - 5:00pm MDT
TBA
  Workshops, Full Day

9:00am MDT

MDMA-Assisted Therapy Advanced Workshop
The safety and efficacy of MDMA-assisted therapy is currently under investigation. It has not yet been approved by the FDA or other regulatory authorities, does not work for everyone, and carries risks even in therapeutic settings.

Additional registration fee applies.

This advanced MDMA-Assisted Therapy Workshop will be open to MAPS’s MDMA-Assisted Therapy Training Program alumni and other experienced practitioners in the psychedelic-assisted therapy field.
Advanced topics of the therapeutic approach will be discussed as they relate to theoretical understanding and practice of the modality, these may include: when to intervene, transference and countertransference, somatic manifestations, and ways to deepen the therapeutic process.
The presenters bring case examples and first-hand experience from their work on the MAPS-sponsored MDMA-assisted therapy clinical trials to share in a lively day of presentation, discussion, and experiential activity.

Instructors to be announced.
Monday June 19, 2023 9:00am - 5:00pm MDT
TBA
  Workshops, Full Day

9:00am MDT

MDMA-Assisted Therapy Introductory Workshop
The safety and efficacy of MDMA-assisted therapy is currently under investigation. It has not yet been approved by the FDA or other regulatory authorities, does not work for everyone, and carries risks even in therapeutic settings.

Additional registration fee applies.

This introductory MDMA-assisted therapy workshop will provide an overview of the therapeutic approach utilized throughout MAPS’s Phase I, II, and III MDMA-assisted therapy clinical trials.
Clinicians interested in MDMA-assisted therapy for PTSD can learn about the treatment design, published study outcomes, and therapeutic approach.
Core elements of the therapeutic approach will be discussed as they relate to theoretical understanding and practice of the modality, these may include: inner healing intelligence, inner-directed process, trusting the process, beginner’s mind, somatic manifestations, person-centered support, therapeutic alliance, and trust.
The presenters bring case examples and first-hand experience from their work on the MAPS-sponsored MDMA-assisted psychotherapy clinical trials to share in a lively day of presentation, discussion, and experiential activity.

Instructors to be announced.
Monday June 19, 2023 9:00am - 5:00pm MDT
TBA
  Workshops, Full Day

9:00am MDT

Psychedelic Fundamentals Workshop
Complimentary, included in any conference registration, but requires pre-registration due to space limitations.

This workshop will include accurate, evidence-based information about psychedelics. The Psychedelic Foundations workshop will cover a range of topics including psychedelic history, science, clinical research, therapeutic uses, and harm reduction.

Instructors include:

  • Andrea Rosati
  • Joseph McCowan, Psy.D.
  • Veronika Gold
  • Yevgeniy Gelfand 
Monday June 19, 2023 9:00am - 5:00pm MDT
TBA
  Workshops, Full Day

9:00am MDT

Psychedelic Integration and Harm Reduction in Clinical Practice
***Please note that this workshop is for licensed professionals only

Psychotherapists and other healthcare providers are increasingly called upon to help clients integrate profoundly meaningful psychedelic experiences into the fabric of their daily lives, resulting in long-term positive changes. This daylong training is designed for clinicians and healthcare providers who want to learn more about current psychedelic research and clinical practice, including how to work with patients who have a history of psychedelic use or have expressed an interest in using psychedelics. The themes of spirituality, ethics, and critical discussion will be woven throughout the program with opportunities for connection, collaboration, and building community.

We will discuss recent and current clinical trials, outcomes, legal status, and what it all means for the future of psychotherapy. We then move to the practicalities of defining integration and how it can occur in a clinical setting. We focus on translating research findings into clinical practice, including working with patients who are considering using psychedelics, currently using psychedelics, or have used them in the past. This program includes discussion of assessment and integration techniques, resources, and legal and ethical issues.
Program participant clinicians will complete the training with a conceptual and practical understanding of how to engage clients in discussions about psychedelics that are balanced, reduce potential for harm, and increase the potential for benefit from these experiences.

Instructors include:

  • Elizabeth Nielson, PhD
  • Ingmar Gorman, PhD
  • Victor Cabral, MSW, LSW, CCTP-I


Monday June 19, 2023 9:00am - 5:00pm MDT
TBA
  Workshops, Full Day

9:00am MDT

Grof® Breathwork: The Legacy of Stanislav Grof
Workshop Schedule

Sunday evening, June 18
Welcome, Introduction +Preparation
6:30pm – 9:30pm

Monday, June 19
Breathwork session #1 Convention Center
9:00am – 5:00pm

Tuesday, June 20
Breathwork session #2 Convention Center
9:00am - 5:00pm

---

Additional registration fee applies.

---

This highly experiential workshop offers an introduction to the theoretical and practical work of Stanislav Grof, whose groundbreaking research into the value of non-ordinary states of consciousness, including psychedelic experiences, remains a bulwark of psychedelic science. Following the prohibition of using psychedelics in research in the 1970s, Stan and his late wife Christina Grof developed holotropic breathwork as a means of inviting non-ordinary states of consciousness through a combination of deep breathing, evocative music, careful attention to set and setting, and individual “energy release work” where appropriate. Supported by a team of experienced practitioners, this workshop offers both a “breathing” and “sitting” experience of Grof® Breathwork, the form of breathwork now practiced and taught internationally by Stan and his current wife Brigitte Grof under their umbrella organization Grof Legacy Training. Valuable as a training tool for supporting psychedelics experiences, Grof® Breathwork attends to careful preparation for experience; ethical, respectful and safe settings; the naturally therapeutic presence critical for effective sitting or guiding; and skillful guidance in the integrative process that follows deep experience.

Instructors include:

  • Stanislav Grof, M.A., Ph.D.
  • Brigitte Grof, MA, Ph.D. (h.c.)
  • Diane Haug, M.A., LPCC
  • Jay Dufrechou, J.D., Ph.D.
Monday June 19, 2023 9:00am - Tuesday June 20, 2023 5:00pm MDT
TBA
  Workshops, Two Full Days
 
Tuesday, June 20
 

9:00am MDT

MDMA-Assisted Therapy Set and Setting Workshop
The safety and efficacy of MDMA-assisted therapy is currently under investigation. It has not yet been approved by the FDA or other regulatory authorities, does not work for everyone, and carries risks even in therapeutic settings.

Additional registration fee applies.

This MDMA-Assisted Therapy Workshop will provide interested clinicians with information covering various ways to foster a set and setting conducive to MDMA-Assisted Therapy sessions.
Presenters will bring case examples and first-hand experience from their work on the MAPS-sponsored MDMA-assisted psychotherapy clinical trials. They will cover topics such as how to support a participant’s mindset, how to “set the stage”, key qualities that make up ideal physical settings and the importance of environmental context. 
Workshop participants will participate in a variety of experiential activities and will have the opportunity to “design” their own therapy room. Interactive discussions and Q&A sessions will be included throughout the morning.

Instructors to be announced.
Tuesday June 20, 2023 9:00am - 1:00pm MDT
TBA
  Workshops, Morning

9:00am MDT

Meditation and Contemplative Science for Psychedelic Practitioners
Additional registration fee applies.

This workshop will explore compassion meditation and contemplative science through insights and techniques drawn from psychology, neuroscience, and contemplative practice. Participants will be invited to experience contemplative exercises that can strengthen and sustain compassion to support resilience and address burnout. Reflective exercises explore mindsets, attitudes, and somatic strategies for building altruistic motivation and sustained compassion as a way of caring for clients and sustaining the energy, outlook, and wellbeing of the psychedelic therapist. With practice, informed compassion can become a spontaneous response that supports practitioners and their clients in moments of distress and dysregulation.

Compassion practices support spiritual health and promote generative response to suffering, thus preventing and addressing burnout. Participants will discover ways to cultivate a non-reactive, stable presence that is able to hold space for non-ordinary states of consciousness, traumatic processing, and the challenging psychedelic experiences of their clients.

Format: The session will include the following elements:

  • Practice: Participants will be guided through a series of intentional and progressive meditation practices that stabilize the mind, orient the body to sources of support, and cultivate a deepening of compassion and altruistic motivation. 
  • Lecture: The neuroscience of compassion will be explored and brought into conversation with psychedelic science and therapeutic practice. A panel of contemplative psychedelic therapy practitioners will present case studies and discuss their experience of sitting with clients in challenging and distressing moments. 
  • Small Group Discussion: Participants will be invited to share their experiences and challenges in a small group setting with facilitation from skilled contemplative practitioners, in order to identify practices and strategies to support their work in the field of psychedelic assisted therapies

Instructors include:

  • Carla Burns, M.Div.
  • Jamie Beachy, Ph.D., M.Div.
  • Jordan Quaglia, Ph.D.
  • Sara Lewis, Ph.D., LCSW
Tuesday June 20, 2023 9:00am - 1:00pm MDT
TBA
  Workshops, Morning

9:00am MDT

Veterans and psychedelic therapy: An introduction for clinicians and care professional
Additional registration fee applies.

This workshop is intended to educate medical and mental health clinicians and other care professionals who work with veterans and their families about the emerging research into the potential of psychedelic-assisted therapies to provide more effective treatments for common indications in this population such as depression, PTSD, and substance abuse disorder.

The workshop covers the basics of psychedelic-assisted therapy; guidance on providing mental health support and treatments to veteran populations; and a briefing on the design and findings of the latest research that is directly related or relevant to veterans.

Instructors include:

  • Amy L. Lehrner Ph.D.
  • Rachel Yehuda, Ph.D.
Tuesday June 20, 2023 9:00am - 1:00pm MDT
TBA
  Workshops, Morning

9:00am MDT

MDMA-Assisted Therapy Advanced Workshop
The safety and efficacy of MDMA-assisted therapy is currently under investigation. It has not yet been approved by the FDA or other regulatory authorities, does not work for everyone, and carries risks even in therapeutic settings.

Additional registration fee applies.

This advanced MDMA-Assisted Therapy Workshop will be open to MAPS’s MDMA-Assisted Therapy Training Program alumni and other experienced practitioners in the psychedelic-assisted therapy field.
Advanced topics of the therapeutic approach will be discussed as they relate to theoretical understanding and practice of the modality, these may include: when to intervene, transference and countertransference, somatic manifestations, and ways to deepen the therapeutic process.
The presenters bring case examples and first-hand experience from their work on the MAPS-sponsored MDMA-assisted therapy clinical trials to share in a lively day of presentation, discussion, and experiential activity.

Instructors to be announced.
Tuesday June 20, 2023 9:00am - 5:00pm MDT
TBA
  Workshops, Full Day

9:00am MDT

MDMA-Assisted Therapy Introductory Workshop
The safety and efficacy of MDMA-assisted therapy is currently under investigation. It has not yet been approved by the FDA or other regulatory authorities, does not work for everyone, and carries risks even in therapeutic settings.

Additional registration fee applies.

This introductory MDMA-assisted therapy workshop will provide an overview of the therapeutic approach utilized throughout MAPS’s Phase I, II, and III MDMA-assisted therapy clinical trials.
Clinicians interested in MDMA-assisted therapy for PTSD can learn about the treatment design, published study outcomes, and therapeutic approach.
Core elements of the therapeutic approach will be discussed as they relate to theoretical understanding and practice of the modality, these may include: inner healing intelligence, inner-directed process, trusting the process, beginner’s mind, somatic manifestations, person-centered support, therapeutic alliance, and trust.
The presenters bring case examples and first-hand experience from their work on the MAPS-sponsored MDMA-assisted psychotherapy clinical trials to share in a lively day of presentation, discussion, and experiential activity.

Instructors to be announced.
Tuesday June 20, 2023 9:00am - 5:00pm MDT
TBA
  Workshops, Full Day

9:00am MDT

Psychedelic Fundamentals Workshop
Complimentary, included in any conference registration, but requires pre-registration due to space limitations.

This workshop will include accurate, evidence-based information about psychedelics. The Psychedelic Foundations workshop will cover a range of topics including psychedelic history, science, clinical research, therapeutic uses, and harm reduction.

Instructors include:

  • Andrea Rosati
  • Joseph McCowan, Psy.D.
  • Veronika Gold
  • Yevgeniy Gelfand 

Tuesday June 20, 2023 9:00am - 5:00pm MDT
TBA
  Workshops, Full Day

9:00am MDT

Psychedelic Therapy for End-of-Life and Palliative Care
Building upon pioneering research from over half a century ago exploring the efficacy and safety of psychedelics for treating psycho-spiritual and existential distress in advanced cancer, research is again investigating the therapeutic utility of psychedelics in end-of-life and palliative care. Clinicians and others interested in novel therapies for treating emotional suffering near the end of life and in hospice and palliative care will learn about the history, scientific findings from FDA-approved trials, and implications of the psychedelic treatment model as they consider how psychedelic psychotherapy might serve their patient populations. This presentation will also include discussions on the nature of emotional suffering in advanced illness, the importance of death awareness, and a description of the psychedelic therapeutic model for palliative care.

Instructors include:

  • Anthony P. Bossis, Ph.D.
  • Brian Anderson, M.D.
  • Charles S. Grob, M.D.
  • Mary Cosimano, LMSW
Tuesday June 20, 2023 9:00am - 5:00pm MDT
TBA
  Workshops, Full Day

9:00am MDT

Zendo Project Peer Support + Harm Reduction Workshop
Complimentary, included in any conference registration, but requires pre-registration due to space limitations.

Because most psychedelic use occurs without adequate preparation and outside of supervised, clinical settings, it is essential that more people understand how to support peers through overwhelming experiences. This workshop will provide participants with professional harm reduction skills, so that they can help others transform those uncomfortable moments into opportunities for healing and growth.
Presenters will provide an overview of the mission and vision of the Zendo Project, delve deep into the guiding principles used to train volunteers, and share reflections from their own experiences with peer support. Participants will also have the opportunity to practice their own peer support skills amongst a variety of experiential activities.
Workshop participants will walk away with an in-depth understanding of how to hold space for someone during a challenging psychedelic experience. They will also leave equipped with a breadth of information and tools necessary for educating and informing others about reducing risks associated with psychedelic use.

Instructors include:

  • Ryan Beauregard
  • Sara Gael M.A., L.P.C.
Tuesday June 20, 2023 9:00am - 5:00pm MDT
TBA
  Workshops, Full Day

1:00pm MDT

MDMA-Assisted Therapy Music Workshop
The safety and efficacy of MDMA-assisted therapy is currently under investigation. It has not yet been approved by the FDA or other regulatory authorities, does not work for everyone, and carries risks even in therapeutic settings.

Additional registration fee applies.

This workshop will give clinicians interested in pursuing MDMA-Assisted Therapy a deep-dive into a critical feature of experiential sessions: “music”.

The presenters bring case examples and first-hand experience from their work on the MAPS-sponsored MDMA-assisted psychotherapy clinical trials. They will touch on core principles regarding the therapeutic functions of music, explain how they create playlists that are conducive to MDMA sessions, and go over strategies for facilitating music to support a variety of therapeutic processes.
To get a glimpse into music’s power and therapeutic influence, workshop participants will listen to an arch of songs curated by MAPS MDMA-assisted therapists after they have been guided into a meditative state. They will also have the opportunity to workshop their own playlists that they can utilize in their current or future psychedelic-assisted therapy work.

Interactive discussions and Q&A sessions will be included throughout the day.

Instructors to be announced.  
Tuesday June 20, 2023 1:00pm - 5:00pm MDT
TBA
  Workshops, Afternoon
 
Wednesday, June 21
 

9:00am MDT

Opening plenary
Wednesday June 21, 2023 9:00am - 10:00am MDT
Colorado Convention Center
  Keynotes

10:00am MDT

Funding the psychedelic economy
Wednesday June 21, 2023 10:00am - 10:00am MDT
Colorado Convention Center
  Business

10:00am MDT

Ethnobotanical approaches to psychedelics
Wednesday June 21, 2023 10:00am - 10:00am MDT
Colorado Convention Center
  Culture

10:00am MDT

Preparing to deliver psychedelic therapy
What will it take to make psychedelic therapy a real treatment option in the North American healthcare system? Those involved in providing care—from therapists to clinic operators, insurance companies, hospitals, drug developers, regulators, business and educational organizations—have a role to play if the rollout of psychedelic therapy is to succeed. This program will address practical concerns across the spectrum of healthcare actors.
Wednesday June 21, 2023 10:00am - 10:00am MDT
Colorado Convention Center
  Healthcare

10:00am MDT

National and regional policy reform in North America
For decades, few policy-makers dared to even mention psychedelics in any other context but risk. Now, with a House caucus focused on psychedelic therapy, bipartisan legislation proposed in the Senate, successful state regulation campaigns, and new access pathways for psychedelic treatments in Canada, a new momentum is gathering. What do the next few years have in store? Join us to explore how activists, community campaigns, and law-makers are paving the way for a post-prohibition future.
Wednesday June 21, 2023 10:00am - 10:00am MDT
Colorado Convention Center
  Policy

10:00am MDT

Neuroscience and pharmacology
Since research began in the 1950s, scientific knowledge of the mechanisms of action and pharmacological properties of psychedelics has made meaningful advances. What does the latest neuroimaging, animal, and in vitro research tell us about the way psychedelic compounds interact with the brain, and how we can leverage these effects for therapeutic benefit? This program will map the current state of the research and suggest future avenues of exploration.
Wednesday June 21, 2023 10:00am - 10:00am MDT
Colorado Convention Center
  Scientific Research

10:00am MDT

Leading therapeutic research topics
Psychedelics, once overlooked by the regulatory and medical community, may show the potential to become viable treatment options for serious mental health and substance use disorders. Both research-based organizations and major research universities have contributed studies and clinical trials. This program will explore the areas of investigation which have advanced furthest in demonstrating psychedelics’ therapeutic potential.
Wednesday June 21, 2023 10:00am - 10:00am MDT
Colorado Convention Center
  Therapy Research

10:30am MDT

The economics of psychedelic drugs and care
Wednesday June 21, 2023 10:30am - 11:30am MDT
Colorado Convention Center
  Business

10:30am MDT

Ethnobotany I
Wednesday June 21, 2023 10:30am - 11:30am MDT
Colorado Convention Center
  Culture

10:30am MDT

Working with regulators for a new therapeutic model
The North American mental health care system has not previously integrated a treatment model in which patients must both take a prescription drug and experience therapy under the supervision of clinical professionals. It remains to be seen how the FDA and other government legislative agencies may regulate this new paradigm of treatment. What challenges remain, and how might these shape the delivery of future psychedelic mental health care services? Come learn directly from regulatory officials and pharmaceutical compliance officers involved in this process.
Wednesday June 21, 2023 10:30am - 11:30am MDT
Colorado Convention Center
  Healthcare

10:30am MDT

The possibility of bipartisan federal drug policy reform in the US
After decades of active disinterest, federal policymakers are now putting psychedelic therapy on the national agenda. Recent activity in both the House and the Senate indicates an openness to rethinking the value of psychedelic therapies. What will it take for these initiatives to impact substance scheduling and research funding? Join us to hear from the advocates and lawmakers working across the aisle to create meaningful change in federal psychedelic legislation.
Wednesday June 21, 2023 10:30am - 11:30am MDT
Colorado Convention Center
  Policy

10:30am MDT

Theories of psychedelic mechanisms and action
Psychedelics have been studied for their unique ability to induce perceptual and experiential shifts that result in lasting changes. What are the mechanisms of action that underlie these often dramatic outcomes? Join us to explore the leading hypotheses for explaining how psychedelics may generate their unique subjective and therapeutic results.
Wednesday June 21, 2023 10:30am - 11:30am MDT
Colorado Convention Center
  Scientific Research

10:30am MDT

PTSD & Trauma I
PTSD affects about twelve million adults in the U.S. any given year. A growing body of research suggests that psychedelic-assisted therapies may produce a significant reduction in PTSD symptoms. Join us to learn how psychedelic-assisted therapies may be harnessed to develop treatments for one of the country's most common mental health challenges.
Wednesday June 21, 2023 10:30am - 11:30am MDT
Colorado Convention Center
  Therapy Research

12:00pm MDT

Public companies, investment banking, and retail investors
Wednesday June 21, 2023 12:00pm - 1:00pm MDT
Colorado Convention Center
  Business

12:00pm MDT

Ethnobotany II
Wednesday June 21, 2023 12:00pm - 1:00pm MDT
Colorado Convention Center
  Culture

12:00pm MDT

Preparing for commercialization of psychedelic-assisted therapy
FDA approval is the only one of many links in the chain that readies a new treatment for clinical adoption. The process involves developing REMS, finding manufacturers and distributor agents, training clinicians, creating accreditation providers, obtaining insurance coverage, and ensuring that the treatment is integrated into the current standards of care. Psychedelic therapy, by its nature, may be an especially complex case. Join us to learn what it will take to make this novel modality a tangible treatment option for patients. 
Wednesday June 21, 2023 12:00pm - 1:00pm MDT
Colorado Convention Center
  Healthcare

12:00pm MDT

Collaborating with veterans and law enforcement
A suicide epidemic among veterans suffering from PTSD, anxiety, depression, and addiction has resulted in over 30,000 deaths since September 11th, 2001. Struggling to address this crisis with established treatments, many have sought out psychedelic therapies both out-of-country and through clinical trials offered by the VA. Now, veterans and law enforcement throughout the country are advocating for access to psychedelic therapy and funding for research. Join us to hear from these leaders and advocates uniquely positioned in the effort to pave the way for reform.
Wednesday June 21, 2023 12:00pm - 1:00pm MDT
Colorado Convention Center
  Policy

12:00pm MDT

Updates on neuroscience investigations I
Wednesday June 21, 2023 12:00pm - 1:00pm MDT
Colorado Convention Center
  Scientific Research

12:00pm MDT

PTSD & Trauma II
Wednesday June 21, 2023 12:00pm - 1:00pm MDT
Colorado Convention Center
  Therapy Research

2:30pm MDT

Private companies, venture funds, and LPs
Wednesday June 21, 2023 2:30pm - 3:30pm MDT
Colorado Convention Center
  Business

2:30pm MDT

Religious and sacramental uses of psychedelics
Wednesday June 21, 2023 2:30pm - 3:30pm MDT
Colorado Convention Center
  Culture

2:30pm MDT

Clinics and the delivery of care
The long-term success and integration of psychedelic therapy into the North American healthcare system will depend on the ability of clinics to provide safe and responsible care to patients. Given the novelty of this treatment modality, as well as the importance of the environmental factors in therapeutic outcomes, this infrastructure must be planned with care. Come learn what new and existing clinics need to consider as they prepare to deliver psychedelic services.
Wednesday June 21, 2023 2:30pm - 3:30pm MDT
Colorado Convention Center
  Healthcare

2:30pm MDT

Updates on regional policy reform in North America I
Wednesday June 21, 2023 2:30pm - 3:30pm MDT
Colorado Convention Center
  Policy

2:30pm MDT

Updates on neuroscience investigations II
Wednesday June 21, 2023 2:30pm - 3:30pm MDT
Colorado Convention Center
  Scientific Research

2:30pm MDT

Depression
Depression is recognized by the World Health Organisation as the leading cause of disability globally. Research into the current paradigm of pharmaceutical antidepressants has plateaued, with newer medications showing next to no increase in effectiveness. Drawing on sixty years of research and modern randomized-controlled trial design, the latest round of investigations into psychedelic-assisted therapies for depression are beginning to produce meaningful results. In 2019, the FDA granted two psilocybin-assisted therapy studies focusing on depression a Breakthrough Designation. Join us to hear the latest updates on this important research.
Wednesday June 21, 2023 2:30pm - 3:30pm MDT
Colorado Convention Center
  Therapy Research

4:00pm MDT

Philanthropic funding and impact investing
Commercial investment comprises the majority of funding in the psychedelic sector, with nearly all investment going to drug discovery over the last two years. Meanwhile, many projects outside of the scope of commercial markets require financial support. By committing strategic funds and financial gifts to mission-driven businesses, drug policy reform, public health education, harm reduction, and diversity and inclusion initiatives, philanthropists and investors have an opportunity to shape the field. In this session, we will explore how constructive capital can build equity and social value in the burgeoning psychedelic economy.
Wednesday June 21, 2023 4:00pm - 5:00pm MDT
Colorado Convention Center
  Business

4:00pm MDT

Conservation, ecology, and psychedelic plants
Wednesday June 21, 2023 4:00pm - 5:00pm MDT
Colorado Convention Center
  Culture

4:00pm MDT

Ensuring inclusive access to psychedelic therapy
Those most in need of treatment for mental health conditions are often those least able to afford services. Psychedelic therapy, which requires long dosage sessions and often multi-week courses of treatment, promises to be even more costly than conventional mental health treatments. What measures can providers take to create equity of access? Join us to consider the moral and public health case for inclusive access, and what it will take to ensure that those populations with the greatest need are able to benefit.
Wednesday June 21, 2023 4:00pm - 5:00pm MDT
Colorado Convention Center
  Healthcare

4:00pm MDT

Updates on regional policy reform in North America II
Wednesday June 21, 2023 4:00pm - 5:00pm MDT
Colorado Convention Center
  Policy

4:00pm MDT

Future directions psychedelic neuroscience
The last decade has seen a meaningful increase in the number and quality of studies in the neuroscience of psychedelics. As research technology improves and more research centers step into the field, the next decade could see even greater strides. What current limitations do researchers hope to overcome, and what do they hope to investigate? Join us to explore the exciting future directions of this quickly evolving field.
Wednesday June 21, 2023 4:00pm - 5:00pm MDT
Colorado Convention Center
  Scientific Research

4:00pm MDT

Addiction and substance abuse disorders
Substance use disorder has become a public health emergency, with the number of afflicted adults across the country jumping from twenty million in 2019 to forty million in the first year of the pandemic. Drug overdose deaths reached over 100,000 nationwide in 2020. Meanwhile, current treatment options apply counseling and behavioral therapies which have high rates of recidivism. Drawing on a long history of research, recent studies are investigating psychedelic-assisted therapy for a variety of new applications in substance use disorders. Join us to consider the role that this potential paradigm for addiction treatment may play and what it will take to confirm its efficacy.
Wednesday June 21, 2023 4:00pm - 5:00pm MDT
Colorado Convention Center
  Therapy Research

5:30pm MDT

Closing plenary
Wednesday June 21, 2023 5:30pm - 6:00pm MDT
Colorado Convention Center
  Keynotes

7:30pm MDT

Wednesday, June 21, 2023 Opening Dinner Honoring Roland R. Griffiths, PhD
Additional registration fee applies.

Featuring Frederick S. Barrett, PhD; Mary Cosimano, LMSW; Rick Doblin, PhD; Robert Jesse; William A. Richards, Ph; David B. Yaden, PhD; and others to be announced.

Join us on the first night of the conference to honor Roland R. Griffiths, PhD, Professor in the Departments of Psychiatry and Neurosciences at the Johns Hopkins University School of Medicine, and founding Director of the Johns Hopkins Center on Psychedelic and Consciousness Research.
Wednesday June 21, 2023 7:30pm - 9:00pm MDT
Colorado Convention Center
  Dinners, Afternoon
 
Thursday, June 22
 

9:00am MDT

Opening plenary
Thursday June 22, 2023 9:00am - 10:00am MDT
Colorado Convention Center
  Keynotes

10:00am MDT

Operating psychedelic companies
Thursday June 22, 2023 10:00am - 10:00am MDT
Colorado Convention Center
  Business

10:00am MDT

Cultural views of the psychedelic renaissance
Thursday June 22, 2023 10:00am - 10:00am MDT
Colorado Convention Center
  Culture

10:00am MDT

Building a psychedelic practitioner community
The role of psychedelic practitioners is of singular importance in the delivery of psychedelic therapy. As this treatment option rolls out to the patient population, the resources and support available to these practitioners will have a direct influence on the ability to provide quality care. This program will consider the various infrastructure and tools, such as community networks, mentors, access to up-to-date research, and accountability systems, required to promote the success of this incipient profession.
Thursday June 22, 2023 10:00am - 10:00am MDT
Colorado Convention Center
  Healthcare

10:00am MDT

Dialogues in psychedelic policy reform
As states and municipalities, and now the federal government, begin to prioritize the revision of antiquated drug laws, new questions are emerging about the various costs and benefits of psychedelic policy reforms. The diversity of reform efforts both at the state level and elsewhere across the globe is significant. What can we learn from a deeper examination of these differences? Join us for a bigger picture view of the various historical, ongoing, and potential future initiatives to create a cogent and publically beneficial drug policy.
Thursday June 22, 2023 10:00am - 10:00am MDT
Colorado Convention Center
  Policy

10:00am MDT

Studying wellness, spirituality, and personal growth
Psychedelics have been studied clinically for their ability to interrupt neurological patterns associated with various mental health conditions. But these same changes in brain activity may also be leveraged by healthy adults looking for deeper meaning and purpose. What measures and protocols are researchers using to study these non-medical uses? This session will explore the role psychedelics could play as tools for personal and spiritual growth.
Thursday June 22, 2023 10:00am - 10:00am MDT
Colorado Convention Center
  Scientific Research

10:00am MDT

Emerging therapeutic research topics
In the last fifteen years, psychedelics have been primarily investigated for treatment of depression, anxiety, and PTSD. More recently, research programs are exploring psychedelic therapies for other psychological and neurological disorders and illnesses, including obsessive compulsive disorder, Alzheimer’s disease, Lyme disease, adjustment disorder, and eating disorders. Join us to learn how these new areas of research may move the field forward.
Thursday June 22, 2023 10:00am - 10:00am MDT
Colorado Convention Center
  Therapy Research

10:30am MDT

Executive leadership in the psychedelic industry
Within the last five years, the foundations of a psychedelic industry have rapidly developed. The pioneering leaders at the edge of this growth face significant risks and unique regulatory, financial, and clinical situations. Join us to hear stories and industry insights about the challenges and opportunities of operating visionary companies.
Thursday June 22, 2023 10:30am - 11:30am MDT
Colorado Convention Center
  Business

10:30am MDT

Indigenous perspectives I
Thursday June 22, 2023 10:30am - 11:30am MDT
Colorado Convention Center
  Culture

10:30am MDT

The varieties of psychedelic care practitioners
Therapists and psychiatrists have been well-represented in the field of psychedelic therapy. A wide variety of practitioners, however, may be qualified and well-suited to guide the course of treatment and guide sessions. Nurses, social workers, counselors, and religious professionals bring a wide array of relevant skills and knowledge-sets. This session will consider the possibility of integrating multiple care professions in the practice of psychedelic therapy, and how this diversity may be a strength of the expanding field.
Thursday June 22, 2023 10:30am - 11:30am MDT
Colorado Convention Center
  Healthcare

10:30am MDT

Decriminalization, legalization, medicalization
The effort to enable psychedelic research and end prohibition has led to a variety of legal pathways across North America. From regional deprioritization, to statewide supervised use, to the possibility of an FDA-approved therapy modality—each strategy has emerged in its own context and with its own unique goals. How can these various frameworks work together, and how will they remain unique? Join us to discover how this complex landscape of legal pathways will impact future access and use of psychedelics.
Thursday June 22, 2023 10:30am - 11:30am MDT
Colorado Convention Center
  Policy

10:30am MDT

Personal growth and spirituality
Psychedelics have been studied clinically for their ability to interrupt neurological patterns associated with various mental health conditions. But these same changes in brain activity may also be leveraged by healthy adults looking for deeper meaning and purpose. What measures and protocols are researchers using to study these non-medical uses? This session will explore the role psychedelics could play as tools for personal and spiritual growth.
Thursday June 22, 2023 10:30am - 11:30am MDT
Colorado Convention Center
  Scientific Research

10:30am MDT

Terminal anxiety and existential distress
Patients at the end of life often have options to manage physical pain; however, few possibilities exist to alleviate the accompanying psychological challenges. Drawing on a body of research that extends back to the 1950s, researchers are currently looking into how psilocybin and other psychedelic compounds, coupled with therapeutic intervention, could reduce depression and anxiety associated with a terminal diagnosis. Join us to learn about the potential for psychedelics to impact existential anxiety and play a role in the future of end-of-life care.
Thursday June 22, 2023 10:30am - 11:30am MDT
Colorado Convention Center
  Therapy Research

12:00pm MDT

Building teams and creating partnerships
In order to participate in this market, businesses creating psychedelic services must rapidly assemble their workforce and forge partnerships both within the community and in the more commercial ecosystem. From insurance companies to hospital networks to research centers, many alliances and business arrangements will be required to make psychedelic services available. Join us to explore strategies for hiring, networking, and expansion in this quick-moving field.
Thursday June 22, 2023 12:00pm - 1:00pm MDT
Colorado Convention Center
  Business

12:00pm MDT

Indigenous perspectives II
Thursday June 22, 2023 12:00pm - 1:00pm MDT
Colorado Convention Center
  Culture

12:00pm MDT

Training psychedelic practitioners
Thursday June 22, 2023 12:00pm - 1:00pm MDT
Colorado Convention Center
  Healthcare

12:00pm MDT

Case studies of psychedelic religious practices in the US
Recently, medicalization and decriminalization have been the two most visible routes to creating psychedelic access. But a third and longer-established route exists: exemptions for spiritual or religious practice. Currently, religious groups like União do Vegetal and the Santo Daime ingest ayahuasca - which contains the Schedule I substance DMT - as an integral part of their religious practice. But the right to do so did not come easily. Join us to consider the complexities of religious and spiritual psychedelic use in the United States, and the various judicial rulings that shape this unique legal route.
Thursday June 22, 2023 12:00pm - 1:00pm MDT
Colorado Convention Center
  Policy

12:00pm MDT

Evaluating the data for microdosing
Microdosing, the practice of regularly ingesting sub-perceptual doses of psychedelics, has received a great deal of coverage in the media in the last few years. The alleged benefits are manifold: improved mood, increased creativity and productivity, mitigation of anxiety and depression, alleviation of headaches, and a greater sense of wellbeing. But what data currently exists? Join us for a critical examination of the facts and fictions regarding this widespread underground practice.
Thursday June 22, 2023 12:00pm - 1:00pm MDT
Colorado Convention Center
  Scientific Research

12:00pm MDT

Behavioral disorders
One in eight people in the world live with a mental health disorder. Many of these are behavioral disorders such as anorexia nervosa and obsessive-compulsive disorder, which are highly comorbid, often associated with extreme suffering and impairment, and have limited treatment options due to complicated etiologies. Psychedelic-assisted therapy, currently under investigation as a treatment for these complex disorders, may also help develop new treatment options and shed light on their underlying causes. Join us to learn what role psychedelic therapies may play in the future of behavioral health.
Thursday June 22, 2023 12:00pm - 1:00pm MDT
Colorado Convention Center
  Therapy Research

2:30pm MDT

Pondering the psychedelic patent pipeline
As universities and companies stake intellectual property claims on psychedelic compounds, applications, and data sets, questions have emerged about the way patents and data exclusivity impact the opportunities for competition, innovation, and access to care. Join us for a nuanced consideration of the economic and cultural implications of intellectual rights within the psychedelic ecosystem.
Thursday June 22, 2023 2:30pm - 3:30pm MDT
Colorado Convention Center
  Business

2:30pm MDT

Indigenous perspectives III
Thursday June 22, 2023 2:30pm - 3:30pm MDT
Colorado Convention Center
  Culture

2:30pm MDT

Ethics and accountability in psychedelic care
Therapists and religious professionals are in a unique position of influence over their patients and congregations. By their very nature, psychedelics put individuals in a state of heightened vulnerability. Great attention must be paid to ethical guidelines and boundaries to prevent and respond to misconduct and abuse. This session will take a candid view of the risks, and consider what it will take to establish a culture of integrity and systems of accountability in the psychedelic profession.
Thursday June 22, 2023 2:30pm - 3:30pm MDT
Colorado Convention Center
  Healthcare

2:30pm MDT

Updates on global psychedelic policy reform
While international drug policy has tended to mirror that of the United State’s prohibitionist approach, times are changing. With a worldwide mental health crisis estimated to cost the global economy approximately two and a half trillion US dollars per year, community advocates and policymakers are responding to the need for new mental health treatments. What national initiatives currently exist? How are these initiatives and legislative changes similar and different from what is happening in North America? Join us to track the growing prominence of psychedelic policy reform on the global stage.
Thursday June 22, 2023 2:30pm - 3:30pm MDT
Colorado Convention Center
  Policy

2:30pm MDT

Psilocybin-Facilitated Experiences and Religious Professionals: Quantitative Outcomes
In 1962, the seminal “Good Friday Experiment” administered psilocybin to seminary students to explore its effect on religiously predisposed subjects. Nearly sixty years later, researchers based at Johns Hopkins University and New York University have expanded this field of inquiry in a study with twenty-four religious leaders representing fifteen distinct organizations. What influence might their unique training and life experience of clergy have on the therapy process? How can its subsequent impacts on spiritual practice and insight be measured? Join us to explore the study design and what the data suggests about the convergence of psychedelic therapy and religious practice.
Thursday June 22, 2023 2:30pm - 3:30pm MDT
Colorado Convention Center
  Scientific Research

2:30pm MDT

Brain injury & neurodegenerative disorders
One in six people worldwide suffer from neurological disorders such as Alzheimer’s disease, multiple sclerosis, epilepsy, and brain injuries. While these conditions have not typically been an area of interest in psychedelic research, recent studies are investigating the ability of psychedelic compounds to modulate neuroinflammation and promote neuroplasticity and neurogenesis. Is it possible that researchers could develop applications for neurological conditions? This session will address the current state of the research into psychedelic therapy for neurorehabilitation.
Thursday June 22, 2023 2:30pm - 3:30pm MDT
Colorado Convention Center
  Therapy Research

4:00pm MDT

Aligning funding, profit, and public benefit
Thursday June 22, 2023 4:00pm - 5:00pm MDT
Colorado Convention Center
  Business

4:00pm MDT

Cultural perspectives I
Thursday June 22, 2023 4:00pm - 5:00pm MDT
Colorado Convention Center
  Culture

4:00pm MDT

Accreditation of care providers
If the field of psychedelic therapy is to establish trust, safety, and reputability, the development of standards of care and certification systems is a priority. Training programs will need vetting; new professionals will need mentors; working psychedelic therapists will need up-to-date information. This session will explore the licensure, certification and administrative requirements of practitioners of psychedelic therapy and the organizations building out this supportive infrastructure.
Thursday June 22, 2023 4:00pm - 5:00pm MDT
Colorado Convention Center
  Healthcare

4:00pm MDT

Reflections on decades of drug policy reform
From the beginning of psychedelic prohibition in the 1970s and through federally-funded DARE-era media campaigns, the task of reforming punitive drug control laws has been enormous. Recently, public perception has shifted, allowing many states and municipalities to revisit psychedelic legislation. Driving this sea change are researchers, activists and educators who have dedicated careers to breaking down stigma and telling a more nuanced narrative about psychedelics. Join us to hear from the figures who have done the most to influence psychedelic policy reform.
Thursday June 22, 2023 4:00pm - 5:00pm MDT
Colorado Convention Center
  Policy

4:00pm MDT

Psilocybin-Facilitated Experiences and Religious Professionals: Qualitative Review
In 1962, the seminal “Good Friday Experiment” administered psilocybin to seminary students to explore its effect on religiously predisposed subjects. Nearly sixty years later, researchers based at Johns Hopkins University and New York University have expanded this field of inquiry in a study with twenty-four religious leaders representing fifteen distinct organizations. What impact has psychedelic therapy had on their personal and professional lives? Join us to hear the stories that have emerged from the project.
Thursday June 22, 2023 4:00pm - 5:00pm MDT
Colorado Convention Center
  Scientific Research

4:00pm MDT

Considering new drugs and diagnoses
An extensive, decades-long body of literature exists on the potential applicability of psychedelic agents such as psilocybin, LSD and MDMA, when used in the context of therapeutic intervention, to treat several psychiatric disorders and neurological diseases. Researchers are also investigating the clinical value of plant-based admixtures used in traditional medicines. What other therapeutic applications might research explore, and what might novel compounds offer the field? Join us to consider new directions in psychedelic therapy research.
Thursday June 22, 2023 4:00pm - 5:00pm MDT
Colorado Convention Center
  Therapy Research

5:30pm MDT

Closing plenary
Thursday June 22, 2023 5:30pm - 6:00pm MDT
Colorado Convention Center
  Keynotes

7:00pm MDT

Thursday, June 22, 2023 Dinner Honoring Veterans and First Responders
Additional registration fee applies.

Speakers and entertainment to be announced shortly.

Join us on the Thursday evening of the conference to honor the veterans, first responders, and their families who support psychedelic science.
Thursday June 22, 2023 7:00pm - 9:00pm MDT
Colorado Convention Center
  Dinners, Afternoon
 
Friday, June 23
 

9:00am MDT

Opening plenary
Friday June 23, 2023 9:00am - 10:00am MDT
Colorado Convention Center
  Keynotes

10:00am MDT

Dialogues in the psychedelic industry
As the psychedelic industry has expanded beyond what was once a loose subculture and research community to include a complex of businesses and funders, new questions have emerged concerning the direction and the potential of the field. Will it be possible to steward a culture of cooperation and reciprocity, and perhaps even “psychedelicize” our idea of business itself? Join us for a visionary conversation about questions of ethics, ethos, and the future of the industry.
Friday June 23, 2023 10:00am - 10:00am MDT
Colorado Convention Center
  Business

10:00am MDT

The culture of psychedelics
Friday June 23, 2023 10:00am - 10:00am MDT
Colorado Convention Center
  Culture

10:00am MDT

Delivering care to communities
Integrating psychedelic therapy into the American healthcare system will require innovations in scalability and delivery. Perhaps the greatest paradigm shift suggested by this new modality is a shift from the individual to the community as a locus of healing. This program will offer a deeper consideration of community-oriented approaches, and examine how we can ensure psychedelic therapy has a positive impact on mental health at the population level.
Friday June 23, 2023 10:00am - 10:00am MDT
Colorado Convention Center
  Healthcare

10:00am MDT

The future of psychedelic policy and law
Drug policy in North America has a complex history, running the gamut from unregulated markets to staunch and punitive prohibition. Recent regional harm reduction, medicalization, and decriminalization initiatives comprise a new chapter in this history. As activists, educators, community organizers, legislators, and voters learn from these efforts, the future could look quite different still. This program will highlight the larger issues at play as we move past prohibition into a new approach to drug laws.
Friday June 23, 2023 10:00am - 10:00am MDT
Colorado Convention Center
  Policy

10:00am MDT

Dialogues in therapeutic research
The very nature of psychedelic therapy, in which context and environment play a significant role in influencing outcomes, poses a unique challenge to those studying its effects in controlled conditions. Drawing on sixty years of history, the field continues to improve upon study designs and develop new practices and protocols. Join us to consider the ways in which researchers are learning to work with the special nature of this possible treatment modality.
Friday June 23, 2023 10:00am - 10:00am MDT
Colorado Convention Center
  Scientific Research

10:00am MDT

Emerging therapeutic drug research
Friday June 23, 2023 10:00am - 10:00am MDT
Colorado Convention Center
  Therapy Research

10:30am MDT

Lessons from the cannabis industry
Thirty-eight states and DC now permit medicinal or recreational marijuana use, giving rise to a $13b cannabis industry. Psychedelic entrepreneurs and activists are looking to this market for lessons. But while the cannabis and psychedelic markets share a similar outline— federal drug prohibition followed by and local and statewide reform initiatives—significant differences exist. Join us to explore what the budding psychedelic marketplace can learn from cannabis, as well as their critical differences.
Friday June 23, 2023 10:30am - 11:30am MDT
Colorado Convention Center
  Business

10:30am MDT

Psychedelics, creativity, and the arts
Friday June 23, 2023 10:30am - 11:30am MDT
Colorado Convention Center
  Culture

10:30am MDT

Community-based approaches to mental healthcare
Friday June 23, 2023 10:30am - 11:30am MDT
Colorado Convention Center
  Healthcare

10:30am MDT

Psychedelics and intellectual property reform
While naturally occurring psychedelics have been used by traditional cultures for generations, companies have recently begun to patent psychedelic therapies and compounds inspired by these traditions. This practice has raised questions about who benefits from the current system of intellectual property rights. Join us to hear from visionary thinkers imagining a system of IP that supports innovation and scientific progress while returning benefit and protecting public health.
Friday June 23, 2023 10:30am - 11:30am MDT
Colorado Convention Center
  Policy

10:30am MDT

Considering placebo and expectation bias effect in psychedelic research
To reduce expectation bias, clinical researchers use double-blinded randomized controlled trials; ideally, neither researchers nor participants knows who has received the placebo. The nature of psychedelics confounds this approach. This session will investigate the effects of expectancy and unblinding in psychedelic research and describe how researchers are creatively approaching these unique conditions.
Friday June 23, 2023 10:30am - 11:30am MDT
Colorado Convention Center
  Scientific Research

10:30am MDT

Ketamine
Ketamine, an Essential Medicine according to the World Health Organization, is a long-established anesthetic with global use in surgery and pain management. Since its FDA approval in 1970, research has focused on the therapeutic benefits of the dissociative states it produces. Ketamine therapy has now shown the potential to treat major depression and addiction. What other possible applications are researchers investigating? Join us to learn about ketamine’s mechanisms of action and its versatility as a clinical tool.
Friday June 23, 2023 10:30am - 11:30am MDT
Colorado Convention Center
  Therapy Research

12:00pm MDT

Reciprocity and equity in the psychedelic industry
Friday June 23, 2023 12:00pm - 1:00pm MDT
Colorado Convention Center
  Business

12:00pm MDT

Looking at psychedelics in the media
Friday June 23, 2023 12:00pm - 1:00pm MDT
Colorado Convention Center
  Culture

12:00pm MDT

Providing culturally-attuned care
Alongside economic and logistic barriers, a lack of consideration for the cultural needs of diverse ethnic populations has deterred many who are most in need from seeking treatment. This same cultural blindness undermines rapport within the therapeutic relationship and, by extension, therapeutic outcomes. This session will consider approaches to psychedelic therapy that center the concerns of disadvantaged racial and ethnic groups.
Friday June 23, 2023 12:00pm - 1:00pm MDT
Colorado Convention Center
  Healthcare

12:00pm MDT

Psychedelics in international conflict resolution
While psychedelic research has typically focused on the treatment of individuals, some researchers are asking if psychedelic therapy could provide a tool for sociopolitical interventions. Both traditionally and in the underground, psychedelics have been used in group contexts. Is it possible to do so with members of conflicting groups in a way that does not bypass historical and ongoing harms? Join us to learn what researchers are discovering about how psychedelics can contribute to reconciliation and peace-building.
Friday June 23, 2023 12:00pm - 1:00pm MDT
Colorado Convention Center
  Policy

12:00pm MDT

Improving study design and treatment protocols in psychedelic research
Psychedelics are a sui generis class of drugs whose effects and best practices were not anticipated by typical regulatory assumptions and trial designs. What lessons have scientists learned from decades of research and data, and how will the next generation of trials and studies offer more robust findings and valuable data? Join us to consider how researchers are innovating and moving the field forward.anticipated by typical regulatory assumptions and trial designs. What lessons have scientists learned from decades of research and data, and how will the next generation of trials and studies offer more robust findings and valuable data? Join us to consider how researchers are innovating and moving the field forward.
Friday June 23, 2023 12:00pm - 1:00pm MDT
Colorado Convention Center
  Scientific Research

12:00pm MDT

Ayahuasca & iboga
Ayahuasca and iboga have deep histories of use which have only recently attracted attention from the medical community. Ongoing research is now evaluating ayahuasca for its potential to positively affect depression and addiction. The West Central African shrub Tabernanthe iboga, specifically the active alkaloid ibogaine, is being studied for use in treatment of substance use disorder and its ability to reduce opioid withdrawal symptoms. This session will consider these ceremonial plant medicines therapeutic possibilities based on evidence-based research.
Friday June 23, 2023 12:00pm - 1:00pm MDT
Colorado Convention Center
  Therapy Research

2:30pm MDT

Can psychedelics be a new kind of industry?
As the psychedelic industry takes shape, many are watching to see if it will reflect the culture and spirit of those traditions which have valued the psychedelic experience for generations. Will open science, benefit sharing initiatives, and commitments to health equity be enough to break the extractive habits of conventional industry? Join us to hear from the leaders working to establish inclusive, value-centered business practices that will bring true benefit to society.
Friday June 23, 2023 2:30pm - 3:30pm MDT
Colorado Convention Center
  Business

2:30pm MDT

Celebrating psychedelic subcultures
Friday June 23, 2023 2:30pm - 3:30pm MDT
Colorado Convention Center
  Culture

2:30pm MDT

Will psychedelic therapy improve public health?
While advocates and researchers have been comfortable speaking about the potential of psychedelic-assisted therapy for individual healing, it remains to be seen how meaningfully these impacts will be felt on society at large. Many conditions will play a role, including access and scalability, as well as the enduring presence of the causes of mental health disorders. In this session, we will take a public health perspective and consider psychedelic therapy’s possible systemic effects.
Friday June 23, 2023 2:30pm - 3:30pm MDT
Colorado Convention Center
  Healthcare

2:30pm MDT

Visioning the post-prohibition future
The harms of drug prohibition have been manifold, from the trauma of individual incarceration to the prevention of research into treatments for numerous mental health conditions. These negative effects have been felt primarily by vulnerable groups and communities of color. A clear need exists for policies that move beyond psychedelics as a criminal issue and instead supports their safe and beneficial use. Join us to hear from the thinkers imagining a visionary new approach to drug laws.
Friday June 23, 2023 2:30pm - 3:30pm MDT
Colorado Convention Center
  Policy

2:30pm MDT

Why do psychedelic therapies work across indications?
Friday June 23, 2023 2:30pm - 3:30pm MDT
Colorado Convention Center
  Scientific Research

2:30pm MDT

DMT & 5-MeO-DMT
Both DMT and 5-MeO-DMT are naturally occurring psychedelics found in a variety of plants and, in the case of the latter, the toad Incilius alvarius. By comparison to other classic psychedelics, these compounds have a short duration of effect and offer dramatic, immersive subjective experience. If proven effective in therapeutic trials, their short duration may provide a significant advantage in cost and scale of treatment. Join us to explore the latest updates in this newer branch of psychedelic-assisted therapy research.
Friday June 23, 2023 2:30pm - 3:30pm MDT
Colorado Convention Center
  Therapy Research

5:30pm MDT

Closing plenary
Friday June 23, 2023 5:30pm - 6:00pm MDT
Colorado Convention Center
  Keynotes
 
Filter sessions
Apply filters to sessions.
Monday, June 19
Tuesday, June 20
Wednesday, June 21
Thursday, June 22
Friday, June 23
  • Business
  • Culture
  • Dinners
  • Healthcare
  • Keynotes
  • Policy
  • Scientific Research
  • Therapy Research
  • Workshops
    • Colorado Convention Center
    TBA